NDC 68071-4859-01 - diclofenac sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-4859
- Requested NDC
- 68071-4859-01
- Package NDCs from labels
- 68071-4859-1, 68071-4859-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-06-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Sodium Gel, 3% | NuCare Pharmaceuticals,Inc. | 2024-06-14 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4859-1 | 2021-02-17 | C162847 | 48780-1 | ba0f9c33-11c4-a910-e053-dadaa90a0b85 | Diclofenac Sodium Gel, 3% |
| 68071-4859-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-11c4-a910-e053-dadaa90a0b85 | Diclofenac Sodium Gel, 3% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4859-1 | diclofenac sodium | 100 g in 1 BOX | GEL | 100 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4859 | DICLOFENAC SODIUM GEL [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240616_8721da56-0f8a-5903-e053-2991aa0a61b5.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Dr. Reddy's Laboratories Inc. | 03abebd6-426a-9d05-3dff-196477389430 | 2025-05-05 | Warnings | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | BluePoint Laboratories | 896e3f7d-88e6-4563-b879-a2757d19fd62 | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Actavis Pharma, Inc. | df8b8660-0c24-4848-8bea-c1b935090c66 | 2025-05-01 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Advagen Pharma Ltd | 72419a68-4c9d-44e0-9b43-922440e2c8d7 | 2025-04-30 | Warnings, Adverse reactions | QTG126297Q |
| up and up arthritis pain reliever | DICLOFENAC SODIUM | Target Corporation | 0b7ae58c-cdaf-4343-a199-7a90bf901eb5 | 2025-04-27 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | NorthStar Rx LLC | c7431496-c0ef-403a-9716-92d942709b3d | 2025-04-25 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Amneal Pharmaceuticals LLC | afd30051-8f59-474b-9972-962a5a871dfb | 2025-04-22 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | GERI-CARE PHARMACEUTICAL CORP | fc08e58c-6323-e667-e053-6394a90ab754 | 2025-04-21 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | RedPharm Drug, Inc. | 4ecb7bdc-4a5e-7444-e054-00144ff88e88 | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclona | LIDOCAINE 4.5%, DICLOFENAC 1% | Clinic Pharma | 3271f9ee-6f8a-1c68-e063-6394a90a8e3b | 2025-04-08 | Warnings, Adverse reactions | QTG126297Q |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| Diclofenac Sodium | DICLOFENAC SODIUM | Bryant Ranch Prepack | 487fa223-f4d9-4ab1-a5af-fb0d93f2bd0e | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | INNOVUS PHARMACEUTICALS, INC. | ad9d2c28-21bc-4f81-9c90-cce6a96d976a | 2025-03-25 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | Preferred Pharmaceuticals Inc. | 6d5243ae-4a1a-4583-9337-085520e1f14a | 2025-03-17 | Boxed warning, Warnings, Adverse reactions | 855642 QTG126297Q |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | c933eaad-ba53-4130-90db-a66f89dfc29f | 2025-03-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Oceanside Pharmaceuticals | c48113e0-9f1e-4086-b18f-3204c0d2a689 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Cipla USA Inc. | daf52f5a-1bb7-4808-ab98-483ab9e8cfa0 | 2025-03-11 | Warnings | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Alembic Pharmaceuticals Limited | 048ede6a-b7cd-4100-8979-519bd44906c8 | 2025-03-11 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | 31b56330-6870-48b7-a8c4-0639e0766b25 | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | Alembic Pharmaceuticals Limited | 11adfe0f-e774-4ccf-8a57-0c7d47aeb0dd | 2025-03-04 | Boxed warning, Warnings, Adverse reactions | 855642 QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.